Source AP ©

Sanofi-Aventis to use Taxotere in treating head and neck cancer in US

The U.S. Food and Drug Administration has approved the use of Sanofi-Aventis’s cancer drug Taxotere to treat another form of the disease, the the world's third largest drug maker said Monday.

The drug can now be used to treat locally advanced head and neck cancer prior to chemoradiotherapy and surgery, Sanofi-Aventis said in a statement.

Advanced clinical trials showed that using Taxotere in combination with standard induction chemotherapy resulted in a more than three year improvement in patient survival rate, the company said.

Taxotere is now approved in Europe and the United States to treat five cancer types: breast cancer, lung cancer, prostate cancer, gastric cancer, and head and neck cancer.

More than 640,000 people worldwide are diagnosed with head and neck cancer each year, and more than 350,000 die from the disease annually, the company said.

Sanofi-Aventis' shares were down 0.1 percent at EUR59.33 (US$84.12) in Paris.

Comments
Russia negotiates with terrorists in Moscow
On the report of Human Rights Watch against the DPRK
On the report of Human Rights Watch against the DPRK
On the report of Human Rights Watch against the DPRK
World War I: Remembering the fallen, and the war criminals
Russia sends assault ships to counter US aircraft carriers in the Mediterranean Sea
Russia sends assault ships to counter US aircraft carriers in the Mediterranean Sea
Russia sends assault ships to counter US aircraft carriers in the Mediterranean Sea
Without INF Treaty, USA can destroy Russian nuclear weapons easily
Norwegians complain of demoralised NATO soldiers
The difference between Polish and Ukrainian nationalism is plain to see
Russia sends assault ships to counter US aircraft carriers in the Mediterranean Sea
Mikhail Gorbachev shares his thoughts on nuclear war
Russia sets S-300 systems in Syria on combat readiness
Without INF Treaty, USA can destroy Russian nuclear weapons easily
World War I: Remembering the fallen, and the war criminals
2018: A critical lack of common sense in world governance
2018: A critical lack of common sense in world governance
2018: A critical lack of common sense in world governance
2018: A critical lack of common sense in world governance
2018: A critical lack of common sense in world governance